HPK1 inhibits CD8+T cell effector gene expression following T cell activation

被引:0
|
作者
Ames, Rachel Y.
Zhao, Rongqi
Mace, Parker
Grant, Adam
Xie, Guorui
Milestone, Heather
Grandcolas, Molly
Fang, Eva
Kiosea, Nicolae
Wong, Stephen
Brovarney, Martin
Jacobson, Scott
Nebalasca, Danilo
Arguello, Jorge
Gomez, Blanca
Kandala, Hiranmayee
Ko, Michelle Y.
Nguyen, Lan
Robles, Omar
Shibuya, Grant
Shakhmin, Anton A.
Tivitmahaisoon, Parcharee
Vi-Anh Vu
Younai, Ashkaan
Zibinsky, Mikhail
Subramanyam, Babu
Poon, Daniel
Ghomi, Mohsen Sabouri
Wustrow, David J.
Kassner, Paul D.
Katibah, George E.
Brockstedt, Dirk G.
机构
关键词
D O I
10.1158/1538-7445.AM2024-2654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2654
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The role of Ndfip1 in CD8+T cell activation and effector function
    Kurzweil, Vanessa
    O'Leary, Claire
    Oliver, Paula
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [2] Induction of polyclonal CD8+T cell activation and effector function by Pertussis toxin
    Murphey, Cathi
    Chang, Steve
    Zhang, Xue
    Arulanandam, Bernard
    Forsthuber, Thomas G.
    CELLULAR IMMUNOLOGY, 2011, 267 (01) : 50 - 55
  • [3] HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders
    Wang, Qin
    Zhu, Xinyi
    Li, Jing
    Xu, Sanjia
    Wang, Ali
    Zhang, Xinwen
    Wang, Xingxing
    Cai, Xiaopeng
    Xing, Haimei
    Liu, Ye
    Liu, Xuesong
    Wang, Zhiwei
    Wang, Lai
    Yuan, Xi
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [4] CD8+T cell activation in pathological giardiasis
    Keselman, Aleksander
    Singer, Steven
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [5] Releasing the break on T cell activation through novel small molecule inhibition of HPK1
    Shen, Minhui
    Bommakanti, Gayathri
    Mele, Deanna
    Grimster, Neil
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] GSDMD Is Required for Effector CD8+T Cell Responses to Lung Cancer Cell
    Lv, T.
    Xi, G.
    Liu, H.
    Zhang, F.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2299 - S2299
  • [7] TIGIT inhibits CD8+T cell effector function during chronic viral infection and cancer
    Grogan, Jane
    Johnston, Robert
    Comps-Agrar, Laetitia
    Hackney, Jason
    Yu, Xin
    Huseni, Mahrukh
    Yang, Yagai
    Eaton, Dan
    Park, Summer
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [8] GLUT-1 transporter expression is up-regulated on human CD4+and CD8+T lymphocytes following T cell activation
    Meng, Huicui
    Turbitt, William J.
    Rogers, Connie J.
    FASEB JOURNAL, 2012, 26
  • [9] CD8+T cell responses to pathogens following lymphopenia
    Hamilton, SE
    Jameson, SC
    FASEB JOURNAL, 2005, 19 (04): : A403 - A403
  • [10] CD4+T cells are required for CD8+T-cell activation but not for CD8+T cell effector function for induction of thyrocyte hyperplasia (TEC H/P) and fibrosis
    Yu, Shiguang
    Sharp, Gordon C.
    Braley-Mullen, Helen
    JOURNAL OF IMMUNOLOGY, 2010, 184